By Andrew Schneider, Alex Boyer and Kai Rajan ( May 15, 2025, 5:52 PM EDT) -- This article is part of a monthly column that reviews the latest issues facing attorneys practicing before the Patent Trial and Appeal Board. In this installment, we examine the relevancy of patent owners' district court arguments.... Law360 is on it, so you are, too. A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Kai Rajan
Trending At The PTAB: The Influence Of Litigation Arguments
ADVERTISEMENT Don't want ads? Subscribe or login now. By Andrew Schneider, Alex Boyer and Kai Rajan ( May 15, 2025, 5:52 PM EDT) -- This article is part of a monthly column that reviews the latest issues facing attorneys practicing before the Patent Trial and Appeal Board. In this installment, we examine the relevancy of patent owners' district court arguments....
Progress Preempted: A Call To Restore The Cornerstone Of § 101
For over a decade since the Supreme Court's Alice decision, questions of patent eligibility have plagued the US patent system. The Federal Circuit has been burdened with development of subject matter eligibility law, due to the inability of Congress to pass legislature, and the refusal of the Supreme Court to address subject matter eligibility since Alice.
Progress preempted: A call to restore the cornerstone of § 101
(March 14, 2025) - Finnegan attorneys Aaron Capron, Kai Rajan, Andrew Schneider and Leith Shafi explain some of the challenges involved in applying the current test for establishing patentable subject matter and provide some solutions. For over a decade since the Supreme Court's Alice decision, questions of patent eligibility have plagued the US patent system.
USPTO's AI Guidance: Where Is The Abstract Idea Analysis?
Is the claim as a whole directed to an abstract idea? Based on the Alice decision, that is the central question that courts ask themselves in determining whether a claim is patent-eligible under 35 U.S.C. § 101. As indicated in Alice, the Supreme Court's primary concern was that claims covering an abstract idea “would pre-empt use ...
USPTO's AI guidance: Where is the abstract idea analysis?
(September 20, 2024) - Finnegan, Henderson, Farabow, Garrett & Dunner LLP attorneys Aaron Capron, Adam Boger, Kai Rajan and Andrew Schneider explain how recent government guidance for evaluating the patent eligibility of artificial intelligence inventions appears inconsistent with case law. Is the claim as a whole directed to an abstract idea?
USPTO's AI Guidance: Where Is the Abstract Idea Analysis?
Is the claim as a whole directed to an abstract idea? Based on the Alice decision, that is the central question that courts ask themselves in determining whether a claim is patent-eligible under 35 U.S.C. § 101. As indicated in Alice, the Supreme Court's primary concern was that claims covering an abstract idea "would pre-empt use ...
Trending At The PTAB: Navigating A Motion To Amend
During post grant trials before the Patent Trial and Appeal Board, patent owners can attempt to amend their claims by filing substitute claims in a motion to amend.
PTAB Issues Notice Of Proposed Rulemaking For Motions To Amend
On Friday, March 1, 2024, the Patent and Trademark Office issued a Notice of Proposed Rulemaking relating to motions to amend before the Patent Trial and Appeal Board. The Proposed Rules, if implemented, will make permanent certain provisions of the current Pilot Program for motions to amend.
Trending at the PTAB: Navigating a Motion to Amend
During post grant trials before the Patent Trial and Appeal Board, patent owners can attempt to amend their claims by filing substitute claims in a motion to amend.
Patenting The 3D Bioprinting Innovations That Combat COVID-19
To print this article, all you need is to be registered or login on Mondaq.com. The COVID-19 pandemic has accelerated advancements in pharmaceutical, medical device and manufacturing technologies due to disrupted supply chains and new demands for treatments and materials. Among them is 3D bioprinting, which involves arranging encapsulated cells or other biological materials (bioinks) using a 3D printer to construct tissue, organs or biocompatible scaffolds that promote tissue growth.
Claim Construction | Lexology
Our claim construction statistics track the bases of claim construction decisions in PTAB final written decisions on the merits. These statistics do not include settlements, requests for adverse judgment, motions to terminate, still-pending cases, requests for rehearing, initial claim constructions in institution decisions, and appellate outcomes.
The 3D Bioprinting Patent Landscape Takes Shape as IP Leaders Emerge
3D bioprinting, a type of 3D printing, is a rapidly growing field with more players entering the arena every day. Complementing this growth, 3D bioprinting patent filings are trending upward. 3D bioprinting is a hot area for intellectual property (IP), given the innovation-rich and young technologies involved. While 3D bioprinting uses some of the additive manufacturing principles of 3D printing, it also has many advancements of its own.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Kai
Contact Kai, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack